→ Denis Poddubnyy, Joachim Sieper, Servet Akar, Santiago Muñoz-Fernández, Hildrun Haibel, Mikhail Protopopov, Elisabeth Altmaier, Fabiana Ganz, Robert D Inman
Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study
https://doi.org/10.1093/rheumatology/keaf447
→ Kai‑Michael Beeh, Karl Scheithe, Heike Schmutzler, Saskia Krüger
Clinically Important Improvements and Disease Stability with Fluticasone Furoate/Umeclidinium/Vilanterol Once‑Daily Single‑Inhaler Triple Therapy in the ELLITHE Trial: A Post Hoc Responder Analysis
https://doi.org/10.1007/s41030-025-00306-1
→ Wolfgang A Schmidt, Marco Alibone, Paul Ludwig, Dominik Obermüller, Franziska Karl, Stephanie Terner, Nils Venhoff
Frequency, diagnosis, and management of polymyalgia rheumatica in Germany—database analysis of medical insurance data
https://doi.org/10.1093/rheumatology/keaf367
→ Stephan Weidinger, Tobias Schadeck, Felix Jacobs, Ansgar Weyergraf, Dariusch Mortazawi, Tobias Hagemann, Fatima Abousamra, Thomas Mosch, Bjoern Fritz & Felix Lauffer
Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study
https://doi.org/10.1007/s13555-025-01373-7
→ Südmeyer M, Pedrosa DJ, Siebecker F, Arlt C, Kopra JJ, Jost WH
Utilization of MANAGE-PD Tool in a Real-World Setting in Germany: A Cross-Sectional Study Brain Sci. 2024 Jun 24;14(7):630. doi: 10.3390/brainsci14070630
PMID: 39061371
https://doi.org/10.3390/brainsci14070630
→ Daniel Weiss, Georg Ebersbach, Jens Carsten Möller, Johannes Schwarz, Carolin Arlt, Björn Fritz, Sven-Christian Sensken, Karla Eggert
Do we start too late? Insights from the real-world non-interventional BALANCE study on the present use of levodopa/carbidopa intestinal gel in advanced Parkinson's disease in Germany and Switzerland
DOI: 10.1016/j.parkreldis.2022.08.018
→ Matthias Augustin, Dominik Beier, Jennifer Branner, Dennis Häckl, Regina Hampel, Thomas Kramps, Hjalmar Kurzen, Hannah Lintener, Nima Melzer, Malina Müller, Petra Staubach, Uwe Schwichtenberg, Christian Termeer, Alexander Zink, Petra Nathan, Marcus Maurer
The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany,
First published: 11 May 2024 https://doi.org/10.1111/jdv.20071
→ Poddubnyy, Denis; Sieper, Joachim; Akar, Servet; Muñoz-Fernández, Santiago; Haibel, Hildrun; Diekhoff, Torsten; Protopopov, Mikhail; Altmaier, Elisabeth; Ganz, Fabiana; Inman, Robert D
Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five-Year International Observational Study.
ACR Open Rheumatol 6(2):p 103–10, Feb 2024. doi: 10.1002/acr2.11642
http://doi.org/10.1002/acr2.11642
→ Kai-Michael Beeh, Karl Scheithe, Heike Schmutzler & Saskia Krüger
Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Once-Daily
Single-Inhaler Triple Therapy for Symptomatic COPD: The ELLITHE Non-Interventional Trial,
International Journal of Chronic Obstructive Pulmonary Disease, , 205-216, DOI: 10.2147/
COPD.S427770
https://doi.org/10.2147/COPD.S427770
![[en]Full service CRO for clinical research, clinical studies, non-interventional studies for the pharma and medical device industry[:][de]Full-service CRO für klinische Forschung, klinische Studien, nicht-interventionelle Studien für die Pharma und Medizinprodukte Industrie[:]](http://www.gkm-therapieforschung.de/wp-content/plugins/revslider/public/assets/assets/dummy.png "Teaser1_Gehirn")
![[:en]concept and study design for clinical studies and non-interventional studies NIS[:][:de]Konzeption und Studiendesign für klinische Studien und nicht-interventionelle Studien NIS[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0000_konzepterstellung1.jpg)
![[:en]medical writing in clinical research[:][:de]Medical writing in der klinischen Forschung[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0001_medical-writing.jpg)
![[:en]clinical operations and project management in clinical research[:][:de]Clinical operations und Projektmanagement in der klinischen Forschung[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0003_projektmanagement.jpg)
![[:en]submission of studies and regulatory requirments for authorities and ethics committees[:][:de]Einreichung von Studien und regulatorische Anforderungen bei Behörden und Ethikkomissionen[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0002_regulatory.jpg)
![[:en]Quality Assurance and compliance with Good Clinical Practice GCP and Standard Operating Procedures SOPs[:][:de]Qualitätssicherung und Einhaltung von Guter Klinischer Praxis GCP und Standard Operating Procedures SOPs[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0005_quality-assurance.jpg)
![[:en]Clinical monitoring ensuring regulatory compliance and Good Clinical Practice GCP[:][:de]Klinisches Monitoring für das Einhalten regulatorischer Anforderungen und gute klinische Praxis GCP[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0004_monitoring.jpg)
![[:en]Data management, database setup and maintenance, data capture and cleaning for EDC eCRF and paper CRF[:][:de] Datenmanagement, Dateineingabe, Datenvalidierung, Datenbank Setup und Pflege für eCRF EDC und Papier CRF[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0006_data-management.jpg)
![[:en]Biostatistical biometric consulting on study design, endpoints, sample size estimation and medical statistics and statistical analysis in clinical research[:][:de]Biostatistische, biometrische Beratung zu Studiendesign, Endpunkte, Fallzahlschätzung sowie medizinische Statistik und statistische Analyse in der klinischen Forschung[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0007_biologics.jpg)
![[:en]vigilance services including AE/SAE management and safety and SUSAR reporting services for clinical studies and non-interventional studies with medicinal products or medical devices[:][:de]Vigilanz Services wie AE/SAE Management und Meldung von Ereignissen und SUSARs für klinische und nicht-interventionelle Studien mit Arzneimitteln und Medizinprodukten[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0008_Vigilance1.jpg)
![[:en]Clinical data, clinical studies and post-marketing follow-up surveillance studies for medical devices [:][:de]Klinische Daten, klinische Prüfung und Post-Marketing Surveillance Studien für Medizinprodukte[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_009_medical-devices.jpg)
![[:de]Beratung, Recherche und Nutzendossier zur Nutzenbewertung gemäß AMNOG[:][:en]Consulting, Research and medical writing for benefit assessment according to German additional benefit dossier[:]](https://www.gkm-therapieforschung.de/wp-content/uploads/2015/04/GKM_Services_0010_Amnog.jpg)
